Effects of Intravenous and Catheter Directed Thrombolytic Therapy with Recombinant Tissue Plasminogen Activator (Alteplase) in Non-Traumatic Acute Limb Ischemia; A Randomized Double-Blind Clinical Trial

Effects of Intravenous and Catheter Directed Thrombolytic Therapy with Recombinant Tissue Plasminogen Activator (Alteplase) in Non-Traumatic Acute Limb Ischemia; A Randomized Double-Blind Clinical Trial

Show other versions (1)

Objective: To evaluate the efficacy and safety of intravenous and catheter directed thrombolysis by recombinant tissue plasminogen activator (Alteplase) in the patients with non-traumatic acute limb ischemia (ALI). Methods: This was a randomized clinical trial being performed between 2009 and 2011...

Full description

Bibliographic Details
Main Authors: Abbas Saroukhani, Hassan Ravari, Masoud Pezeshki Rad
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2015-07-01
Series:Bulletin of Emergency and Trauma
Subjects:
Thrombolytic therapy
Tissue plasminogen activator (t-PA)
Acute limb ischemia
Catheter-directed thrombolysis
Intravenous thrombolysis
Alteplase
Online Access:http://www.beat-journal.com/BEATJournal/index.php/BEAT/article/view/127/376

Internet

http://www.beat-journal.com/BEATJournal/index.php/BEAT/article/view/127/376

Similar Items